Webinars take place every Tuesdays via Zoom at 3 pm or 4 pm (Helsinki time; EST). Max time 45 min + 15 min discussion
Webinares hosted by Prof. Mikko Airavaara, Faculty of Pharmacy, University of Helsinki
Seminars/Webinars 2020-2022
1.2.2022 at 3 pm, Glutamine Antagonist Prodrug Discovery: “A story of “BENCH 2 BEDSIDE”
8.3.2022, 3 pm; Novel applications of solubilizing properties of safe and economic solids in various fields of pharmacy giving green methods minimizing the use of harmful organic solvents"
15.3.2022, 4 pm; A Framework to Optimize Research Rigor and Reproducibility
29.3.2022, 3 pm; Gut brain axis in alcohol use disorder
5.4.2022, 3pm; The Tetrazine Ligation - A bioorthogonal reaction for Organic Chemistry in humans
19.4.2022; 3 pm.; Pregnancy - window to woman's health offering possibility to primary prevention.
26.4.2022, 3 pm.; Astrocytes - a possible treatment target to halt Alzheimer’s disease progression
3.5.2022, 3 pm; Cell type-specific vulnerability of striatal neurons in Huntington's disease
10.5.2022, 3 pm; New non-inclusion a-syn aggregate neuropathology – how to detect it, does it matter and can we counteract it?
-
26.10.2021; Prodrug strategies to overcome problems in drug therapy
2.11.2021; Animal models in drug discovery and development - a CRO perspective
15.11.2021, NOTE ON MONDAY!, From inhibitors to ligands – PREP modulation in the models of neurodegenerative disease
23.11.2021, Cause and effect of variation in drug transporter activity
30.11.2021; Ultra-high loaded nanoformulations of poorly soluble drugs and drug candidates: Structure-property relationships, safety and efficacy
7.12.2021
14.12.2021; HSD17B-enzymes: Potential drug targets for modulating of steroid and lipid synthesis
12.01.2021: Explorations into the medicinal chemistry of the abietanes: a tale of innovative antimicrobial compounds and materials |
|---|
19.01.2021: Additive Manufacture of Medicines – 3D Printing, the 4th industrial revolution in manufacture |
|---|
02.02.2021: Identifying and monitoring druggable pathways in neurons |
|---|
09.02.2021: Cell-based in vitro models for the validation of no-systemic drug delivery |
|---|
16.02.2021: Evolution of small chemical entities towards amorphous solid dispersions |
|---|
02.03.2021: Rapid-acting antidepressants and sleep |
|---|
09.03.2021: Needleless electrospinning of nanofibers |
|---|
30.03.2021: Scientific writing and publishing – insights from an editor |
|---|
06.04.2021: Functional Materials in Biomedical Engineering |
|---|
20.04.2021: Nanomedicine in Pharma perspective: past, present and future |
|---|
11.05.2021: 3DP: from nano to devices |
|---|
18.05.2021: Homing peptides and precision nanomedicine |
|---|
29.9.2020 |
The virtual intestine – a simulation environment to understand advanced drug delivery |
|---|
7.10.2020 |
Pharma Industry Finland |
|---|
13.10.2020 |
Treating genital infections: is current treatment the best we can do? |
|---|
21.10.2020 |
Ultrasound-enhanced drug delivery using nanoparticle-stabilized microbubbles |
|---|
3.11.2020 |
Microarray patches for transdermal drug delivery and diagnostic approaches |
|---|